SCHEMBL3672714

SCHEMBL3672714

Fc1cncc(C(CNC2=NCCO2)c2cccc(F)c2F)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3665641 0.90 ADRA2A (0.33) IDH1
SCHEMBL3671320 0.83 TAAR1 (0.40)
SCHEMBL3670065 0.75 TAAR1 (0.38)
SCHEMBL3673459 0.75 P2RX7 (0.41)
SCHEMBL3672711 0.75 GRIN1 (0.33) IDH1
SCHEMBL3411857 0.75 CFB (0.36)
SCHEMBL3669311 0.73 CFB (0.36)
SCHEMBL3804488 0.71 TAAR1 (0.40)
SCHEMBL3674513 0.69 P2RX7 (0.42)
SCHEMBL3668500 0.69 CFB (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240468-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2010-10-20 EP disclosed
WO-2009091759-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-07-23 WO disclosed